高级检索
当前位置: 首页 > 详情页

Necroptosis-Related miRNA Biomarkers for Predicting Overall Survival Outcomes for Endometrial Cancer

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Gynecol Oncol, Tianjin, Peoples R China [2]Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China [3]Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China [4]Capital Med Univ, Beijing Friendship Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China
出处:
ISSN:

关键词: necroptosis miRNA endometrial cancer prognosis biomarker

摘要:
Endometrial cancer (EC) is the gynecological tumor with the highest incidence. In recent years, it has been proved that necroptosis is a method of cell death related to EC. However, the expression of necroptosis-related miRNA in EC and its correlation with prognosis still ill-defined. Use the Cancer Genome Atlas (TCGA) cohort to obtain prognostic data and related clinical data for ECs and normal endometrium tissues. In this study, we identified three necroptotic regulatory miRNAs that are necroptosis-related and survival-related miRNAs (DENSMs) between normal endometrium tissues and EC from 13 necroptosis-related miRNAs. The three DENSMs signature was built to develop prognostic model and classified all EC patients into a high or low risk group. EC patients in the low-risk group showed significantly higher survival possibilities than those in the high-risk group (p = 0.0242), and the risk score was found to be an independent prognosis factor for predicting the OS of EC patients (p = 0.0254) in multivariate Cox regression. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed dephosphorylation, microtubule, protein serine/threonine kinase activity, PI3K-Akt signaling pathway and MAPK signaling pathway are closely related to it. In conclusion, the risk prediction model based on necroptosis-related miRNAs can effectively predict the prognosis of EC patients.

语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 3 区 生物学
小类 | 3 区 遗传学
最新[2025]版:
大类 | 3 区 生物学
小类 | 3 区 遗传学
JCR分区:
出版当年[2020]版:
Q2 GENETICS & HEREDITY
最新[2023]版:
Q2 GENETICS & HEREDITY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2020版] 出版当年五年平均[2016-2020] 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者单位: [1]Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Gynecol Oncol, Tianjin, Peoples R China [2]Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China [3]Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China
通讯作者:
通讯机构: [1]Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Gynecol Oncol, Tianjin, Peoples R China [2]Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China [3]Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)